Sydkystens Slanke & Skønhedsklinik IVS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  18.9% 22.5% 22.0% 12.0% 13.8%  
Credit score (0-100)  9 5 5 21 16  
Credit rating  B B B BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  207 297 107 161 0  
Gross profit  30.2 83.8 -5.6 3.8 35.0  
EBITDA  -42.0 -67.9 -50.6 3.8 -12.6  
EBIT  -47.0 -72.8 -61.5 3.8 -12.6  
Pre-tax profit (PTP)  -47.4 -73.0 -62.3 0.6 -12.8  
Net earnings  -36.2 -57.2 -48.7 -0.4 -10.1  
Pre-tax profit without non-rec. items  -47.4 -73.0 -62.3 0.6 -12.8  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  15.8 10.9 0.0 0.0 0.0  
Shareholders equity total  3.0 4.6 3.9 3.5 3.5  
Interest-bearing liabilities  0.0 0.0 0.0 48.4 40.8  
Balance sheet total (assets)  72.3 73.5 67.7 60.8 63.0  

Net Debt  -11.9 -2.8 -2.3 45.8 40.3  
 
See the entire balance sheet

Volume 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  207 297 107 161 0  
Net sales growth  0.0% 44.0% -64.1% 50.6% -100.0%  
Gross profit  30.2 83.8 -5.6 3.8 35.0  
Gross profit growth  0.0% 177.9% 0.0% 0.0% 828.4%  
Employees  1 0 0 0 0  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 -47.5  
Balance sheet total (assets)  72 73 68 61 63  
Balance sheet change%  0.0% 1.6% -7.8% -10.3% 3.7%  
Added value  -42.0 -67.9 -50.6 14.6 35.0  
Added value %  -20.3% -22.8% -47.4% 9.1% 0.0%  
Investments  11 -10 -22 0 0  

Net sales trend  0.0 1.0 -1.0 1.0 -1.0  
EBIT trend  -1.0 -2.0 -3.0 1.0 -1.0  

Profitability 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  -20.3% -22.8% -47.4% 2.3% 0.0%  
EBIT %  -22.7% -24.5% -57.6% 2.3% 0.0%  
EBIT to gross profit (%)  -155.7% -86.9% 1,105.8% 100.0% -35.9%  
Net Earnings %  -17.5% -19.2% -45.6% -0.2% 0.0%  
Profit before depreciation and extraordinary items %  -15.1% -17.6% -35.4% -0.2% 0.0%  
Pre tax profit less extraordinaries %  -22.9% -24.5% -58.3% 0.4% 0.0%  
ROA %  -64.9% -99.9% -87.1% 5.9% -20.3%  
ROI %  -1,565.7% -1,907.2% -1,438.0% 13.5% -26.1%  
ROE %  -1,206.2% -1,498.0% -1,139.3% -9.8% -288.0%  

Solidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  4.1% 6.3% 5.8% 5.8% 5.5%  
Relative indebtedness %  33.6% 23.1% 59.7% 35.6% 0.0%  
Relative net indebtedness %  27.8% 22.2% 57.5% 34.0% 0.0%  
Net int. bear. debt to EBITDA, %  28.3% 4.1% 4.6% 1,217.2% -321.4%  
Gearing %  0.0% 0.0% 0.0% 1,364.3% 1,178.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 13.2% 0.5%  

Liquidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  0.7 0.6 0.8 0.7 0.7  
Current Ratio  0.8 0.9 1.1 1.1 1.1  
Cash and cash equivalent  11.9 2.8 2.3 2.6 0.4  

Capital use efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 21.4 0.0 0.0  
Trade creditors turnover (days)  112.4 92.1 206.2 0.0 0.0  
Current assets / Net sales %  27.4% 21.1% 63.4% 37.8% 0.0%  
Net working capital  -12.8 -6.2 3.9 3.5 3.5  
Net working capital %  -6.2% -2.1% 3.7% 2.2% 0.0%  

Employee efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  207 0 0 0 0  
Added value / employee  -42 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -42 0 0 0 0  
EBIT / employee  -47 0 0 0 0  
Net earnings / employee  -36 0 0 0 0